11
Table 3. Diabetes-Specific Risk Enhancers That Are
Independent of Other Risk Factors in Diabetes
Mellitus
Risk Enhancers
Long duration (≥10 years for type 2 diabetes mellitus or ≥20 years for type 1 diabetes
mellitus
Albuminuria ≥30 mcg of albumin/mg creatinine
eGFR <60 mL/min/1.73 m
2
Retinopathy
Neuropathy
ABI <0.9
4.4. Primary Prevention
➤ Primary prevention of ASCVD over the life span requires attention to
prevention or management of ASCVD risk factors beginning early in
life (Figure 2).
4.4.1. Evaluation and Risk Assessment
➤ Moderate intensity generic statins allow for efficacious and cost-
effective primary prevention in patients with a 10-year risk of ASCVD
≥7.5%.
